# EXP-20260822-017 independent artifact audit

## Local release checks

The runner completed its atomic staged-bundle validation. Independent local
checks reproduced:

- manifest and implementation-boundary verification;
- `1290` context rows, `1290` endpoint rows, and two inference rows;
- all four CSV artifact hashes in `summary.json`;
- the normalized summary self-digest;
- terminal `FEASIBILITY_ONLY`, `confirmatory_claim: false`, and
  `overall_pass: false` labels;
- Avana and KY design powers `0.9941` and `0.7521`;
- Avana delta `-0.6240834452` with lineage-consistency failure in Cervix and
  Prostate;
- KY delta `-0.5397973951` with all six nominal gates passing.

## Independent post-execution audit

The independent artifact auditor recomputed the endpoint-derived receipts,
hashes, inference, and claim boundary. All computational and integrity checks
matched. The only initial release blocker was the missing evidence-tier label in
`result.md`; after remediation, the release gate is **GO** with the exact label
`T1 descriptive association only; not T2/confirmatory`. No confirmatory,
clinical, treatment, or clean replication claim is permitted.
